The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...
The FDA has warned Sanofi about a series of “significant” manufacturing problems, including contamination, at a key facility ...
The FDA issued a warning letter to Sanofi regarding significant manufacturing violations at its Genzyme Corporation Facility in Framingham, Mass. The letter, dated Dec. 16, 2024, and amended Jan. 15, ...
Despite receiving a prior wrist slap from the FDA in the shape of a Form 483, Sanofi is still working to right the ship at a ...
Good morning! Here are the five things you need to know in local business news to start your busy — and still very cold — ...
Sisitsky submitted his plan to comply with the law late last month after city councilors voted to table discussing the issue until February.